When Ginkgo Bioworks’ head of codebase Dr Patrick Boyle was working on his doctoral research between 2006-12, he was “basically ordering DNA one gene at a time,” he recalls. “I think I ordered less ...

A multibillion-dollar SPAC deal? Check. An international acquisition? Check. An mRNA vaccine production "breakthrough?" Ginkgo Bioworks says it has that, too. With its latest manufacturing update, ...

Patrick Boyle is Interim Chief Scientific Officer at ATCC and a Founding Partner at American Wetware, a design studio for biology. A bioengineer with more than 20 years of experience, he applies ...

Nine Brown and RISD students had the unique opportunity Thursday to tour the laboratory of Ginkgo Bioworks, a major biotechnology company, to learn more about the new field of biological design. The ...

Sumitomo Chemical is expanding its collaboration with the synthetic biology company Ginkgo Bioworks. In a new agreement, Ginkgo will provide engineered microbes capable of producing an undisclosed ...